Lund Melanoma Study Group
31 – 40 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cohort profile : The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort
da Silva, Marisa LU
; Fritz, Josef
LU
; Mboya, Innocent B
LU
; Sun, Ming
LU
; Wahlström, Jens
; van Guelpen, Bethany
; Michaëlsson, Karl
; Magnusson, Patrik K E
; Melander, Olle
LU
and Sandin, Sven
, et al.
(2024)
In BMJ Open
14(7).
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
Huss, Linnea LU ; Gulz-Haake, Igis LU ; Nilsson, Emma LU ; Tryggvadottir, Helga LU ; Nilsson, Linn LU ; Nodin, Björn LU ; Jirström, Karin LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
(2024)
In Nutrients
16(7).
p.1-15
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Lauss, Martin LU ; Phung, Bengt LU ; Borch, Troels Holz ; Harbst, Katja LU
; Kaminska, Kamila
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Yuan, Joan
LU
; Nielsen, Kari
LU
and Ingvar, Christian
LU
, et al.
(2024)
In Nature Communications
15(1).
- Contribution to journal › Article
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
Roostee, Suze LU
; Ehinger, Daniel
LU
; Jönsson, Mats
LU
; Phung, Bengt
LU
; Jönsson, Göran
LU
; Sjödahl, Gottfrid
LU
; Staaf, Johan
LU
and Aine, Mattias
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher LU
; Khazaei, Somayeh
LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Nodin, Björn
LU
; Jirström, Karin
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In PLoS ONE
19(7).
p.1-21
- Contribution to journal › Article
-
Mark
Cost of Illness of Head and Neck Cancer in Sweden
Silfverschiöld, Maria LU
; Jarl, Johan
LU
; Hafström, Anna
LU
; Greiff, Lennart
LU
and Sjövall, Johanna
LU
(2024)
In Value in Health
27(4).
p.425-432
- Contribution to journal › Article
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
Helkkula, Teo LU ; Christensen, Gustav LU ; Ingvar, Christian LU ; Isaksson, Karolin LU ; Harbst, Katja LU
; Persson, Bertil
LU
; Ingvar
LU
; Hafström, Anna
LU
; Carneiro, Ana
LU
and Gaspar, Viktoria
LU
, et al.
(2024)
In BMJ Open
14(2).
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
-
Mark
Risk factors and diagnostic tools in the skin cancer era
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
Nilsson, Linn LU ; Khazaei, Somayeh LU ; Tryggvadottir, Helga LU ; Björner, Sofie LU ; Bressan, Alessandra ; Jirström, Karin LU
; Adrian, Gabriel
LU
; Falck, Anna-Karin
LU
; Borgquist, Signe
LU
and Isaksson, Karolin
LU
, et al.
(2024)
In Clinical Breast Cancer
24(3).
p.152-166
- Contribution to journal › Article